Stockscreener 앱 받기
17.25
3.90%
-0.70
시간 외 거래:
17.25
전일 마감가:
$17.95
열려 있는:
$17.85
하루 거래량:
2,313
Relative Volume:
0.65
시가총액:
$414.44M
수익:
$1.70M
순이익/손실:
$-47.01M
주가수익비율:
-10.15
EPS:
-1.7
순현금흐름:
$-157.28M
1주 성능:
-9.63%
1개월 성능:
-4.59%
6개월 성능:
-9.69%
1년 성능:
-17.86%
1일 변동 폭
$17.25
$17.86
1주일 범위
$17.25
$18.37
52주 변동 폭
$13.30
$25.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
PRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
17.25 | 440.64M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
Puretech Health Plc Adr 주식(PRTC)의 최신 뉴스
PureTech Health (NASDAQ:PRTC) Shares Down 7.3% – Here’s What Happened - Defense World
PureTech Health names Robert Lyne as interim CEO as Chowrira departs By Investing.com - Investing.com India
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health announces board leadership transition By Investing.com - Investing.com South Africa
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces board chair Raju Kucherlapati steps down - Investing.com
PureTech Health issues shares to executives following RSU vesting - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
PureTech set for Jefferies Global Healthcare Conference chat By Investing.com - Investing.com India
PureTech set for Jefferies Global Healthcare Conference chat - Investing.com
PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial - Placera.se
PureTech research reveals gaps in IPF patient care - Investing.com
PureTech research reveals gaps in IPF patient care By Investing.com - Investing.com South Africa
PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... By GuruFocus - Investing.com Canada
PureTech Health to release annual financial results April 30 - Investing.com
PureTech Health to release annual financial results April 30 By Investing.com - Investing.com South Africa
PureTech Health enlists Peel Hunt as joint broker - Investing.com
PureTech Health enlists Peel Hunt as joint broker By Investing.com - Investing.com India
Invesco Ltd: Form 8.3PureTech Health PLC; Opening Position disclosure - The Manila Times
PureTech Health in potential acquisition talks with Nordic Capital By Investing.com - Investing.com South Africa
PureTech Health in potential acquisition talks with Nordic Capital - Investing.com India
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health issues shares to executives after RSU vesting - Investing.com India
PureTech Health issues shares to executives after RSU vesting By Investing.com - Investing.com South Africa
PureTech set for fireside chat at global healthcare event - Investing.com India
PureTech set for fireside chat at global healthcare event By Investing.com - Investing.com South Africa
FDA fast tracks PureTech's leukemia treatment - Investing.com
PureTech to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Top Biotech Stocks: Exploring Innovation Opportunities - MarketBeat
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
This Emerging Market Could Be The Next Big Thing In Biotech - Barchart.com
Royalty Pharma and PureTech Health Enter KarXT Royalty Agreement for Up to $500M - Investing.com India
The Petri Dish: 1910 Genetics hires CBO; PureTech calls off merger - The Business Journals
Has Nextgen Healthcare (NXGN) Outpaced Other Medical Stocks This Year? - Nasdaq
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Nasdaq
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Puretech Health Plc Adr (PRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):